Sign up to save your podcasts
Or
Share The View from 13,000 Feet: Outside Perspective on Tackling M&A and Alliances in Pharmaceuticals and Biotechnology
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The View from 13,000 Feet: Outside Perspective on Tackling M&A and Alliances in Pharmaceuticals and Biotechnology
The success of Alliance-Management groups in pharmaceutical and biotechnology companies has naturally led to their involvement in M&A integrations as well. At the Association of Strategic Alliances Professionals (ASAP) Bio-Pharma Conference in September 2020, senior Alliance leaders discussed this new role.
In this episode, Mike Leonetti, ASAP CEO and Laura McCluer a leading Alliance-Management executive, discuss the major themes from those discussions with host, Nick Palmer, BTD Partner.
CLICK HERE to follow us on LinkedIn
www.btd.consulting
View all episodes
By Carlos Keener, Nick Palmer and Guests
5
11 ratings
The success of Alliance-Management groups in pharmaceutical and biotechnology companies has naturally led to their involvement in M&A integrations as well. At the Association of Strategic Alliances Professionals (ASAP) Bio-Pharma Conference in September 2020, senior Alliance leaders discussed this new role.
In this episode, Mike Leonetti, ASAP CEO and Laura McCluer a leading Alliance-Management executive, discuss the major themes from those discussions with host, Nick Palmer, BTD Partner.
CLICK HERE to follow us on LinkedIn
www.btd.consulting